Revelation Biosciences (REVB) Misses Q2 EPS by 4c

Revelation Biosciences (NASDAQ: REVB) reported Q2 EPS of ($0.87), $0.04 worse than the analyst estimate of ($0.83).

For earnings history and earnings-related data on Revelation Biosciences (REVB) click here.

You May Also Be Interested In

• Active options: NVDA TSLA SPCX MU AAPL INTC CRWV
• Tutor Perini unit wins $42M construction contract in Saudi Arabia
• Capstone Energy+, Inc. (CEPL) Reports Q2 Loss of $0.03